FOXO1 and leukemia: Importantly, these studies provided direct comparisons between FOXO1 and TCF1-overexpressing CAR-T cells, demonstrating FOXO1 reduced exhaustion, improved expansion, and enhanced in vivo outcomes in a model of leukaemia (164, 165)vghy.